학술논문
Optimization of an Imidazo[1,2-a]pyridine Series to Afford Highly Selective Type I1/2 Dual Mer/Axl Kinase Inhibitors within VivoEfficacy
Document Type
Article
Author
McCoull, W.; Boyd, S.; Collingwood, O.; Davies, N.L.; Fairley, G.; Goldberg, K.; Hardaker, E.; Lindsay, N.; Mao, Y.; Markandu, R.; McMurray, L.; McLean, N.; Nissink, J.W.; Travers, J.; Troup, R.I.; Walton, J.; Wilkinson, S.; Williamson, B.; Winter-Holt, J.; Smith, P.D.; Brown, M.R.; Hopcroft, P.; Hodgson, G.; Jackson, A.; Pflug, A.; Rawlins, P.B.; Rivers, E.; Schimpl, M.; Coen, M.; Doherty, A.; Reddy, V.P.; Smith, G.F.; Lainé, A.-L.; Karmokar, A.; Mooney, L.; Musgrove, H.; Hennessy, E.J.; Tentarelli, S.; He, G.; Jiang, X.; Wang, C.; Yang, D.; Zheng, Y.; Zhu, Q.
Source
In: Journal of Medicinal Chemistry . (Journal of Medicinal Chemistry, 23 September 2021, 64(18):13524-13539)
Subject
Language
English
ISSN
15204804
00222623
00222623